Acute modulation of myocardial function by angiotensin 1-7

Peptides

Volumn 30, Issue 9, 2009, Pages 1714-1719

  Castro Chaves, Paulo ^a   Pintalhao, Mariana ^a   Fontes Carvalho, Ricardo ^a   Cerqueira, Rui ^a   Leite Moreira, Adelino F ^a  

^a University of Porto   (Portugal)

Author keywords

Angiotensin 1 7; Contractility; Myocardial function; Relaxation

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; G PROTEIN COUPLED RECEPTOR; HEPTAPEPTIDE; N(G) NITROARGININE; NITRIC OXIDE; RENIN; TRITON X 100;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOCARDIUM; ENDOTHELIAL DYSFUNCTION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE DP-DT; HEART MUSCLE ISCHEMIA; HEART MUSCLE RELAXATION; HEART MUSCLE TENSION; HEART PAPILLARY MUSCLE; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECEPTOR BINDING; RECEPTOR UPREGULATION;

ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; DIASTOLE; ENDOTHELIUM, VASCULAR; IMIDAZOLES; MALE; MYOCARDIAL CONTRACTION; NAPHTHYRIDINES; NITROARGININE; PAPILLARY MUSCLES; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS; PYRIDINES; RABBITS; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, G-PROTEIN-COUPLED;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 67849086680     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.06.008     Document Type: Article

References (30)

1. Averill D.B., Ishiyama Y., Chappell M.C., and Ferrario C.M. Cardiac angiotensin-(1-7) in ischemic cardiomyopathy. Circulation 108 (2003) 2141-2146
2. Brosnihan K.B., Li P., and Ferrario C.M. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 27 (1996) 523-528
3. Brutsaert D.L., Meulemans A.L., Sipido K.R., and Sys S.U. Effects of damaging the endocardial surface on the mechanical performance of isolated cardiac muscle. Circ Res 62 (1988) 358-366
4. Castro C.H., Santos R.A., Ferreira A.J., Bader M., Alenina N., and Almeida A.P. Evidence for a functional interaction of the angiotensin-(1-7) receptor Mas with AT1 and AT2 receptors in the mouse heart. Hypertension 46 (2005) 937-942
5. Chappell M.C., Pirro N.T., Sykes A., and Ferrario C.M. Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme. Hypertension 31 (1998) 362-367
6. Crackower M.A., Sarao R., Oudit G.Y., Yagil C., Kozieradzki I., Scanga S.E., et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417 (2002) 822-828
7. Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87 (2000) E1-9
8. Donoghue M., Wakimoto H., Maguire C.T., Acton S., Hales P., Stagliano N., et al. Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins. J Mol Cell Cardiol 35 (2003) 1043-1053
9. Ferrario C.M. Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research. J Renin Angiotensin Aldosterone Syst 7 (2006) 3-14
10. Ferrario C.M., Trask A.J., and Jessup J.A. Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol 289 (2005) H2281-H2290
11. Gurley S.B., Allred A., Le T.H., Griffiths R., Mao L., Philip N., et al. Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. J Clin Invest 116 (2006) 2218-2225
12. Iyer S.N., Ferrario C.M., and Chappell M.C. Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system. Hypertension 31 (1998) 356-361
13. Keidar S., Kaplan M., and Gamliel-Lazarovich A. ACE2 of the heart: from angiotensin I to angiotensin (1-7). Cardiovasc Res 73 (2007) 463-469
14. Kim S., and Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 52 (2000) 11-34
15. Leite-Moreira A.F., and Bras-Silva C. Inotropic effects of ETB receptor stimulation and their modulation by endocardial endothelium, NO, and prostaglandins. Am J Physiol Heart Circ Physiol 287 (2004) H1194-H1199
16. + exchanger-mediated effect. Am J Physiol Heart Circ Physiol 284 (2003) H1332-H1339
17. Mahon J.M., Carr R.D., Nicol A.K., and Henderson I.W. Angiotensin(1-7) is an antagonist at the type 1 angiotensin II receptor. J Hypertens 12 (1994) 1377-1381
18. Mercure C., Yogi A., Callera G.E., Aranha A.B., Bader M., Ferreira A.J., et al. Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart. Circ Res 103 (2008) 1319-1326
19. Paul M., Poyan Mehr A., and Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 86 (2006) 747-803
20. Porsti I., Bara A.T., Busse R., and Hecker M. Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. Br J Pharmacol 111 (1994) 652-654
21. Ren Y., Garvin J.L., and Carretero O.A. Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles. Hypertension 39 (2002) 799-802
22. Rowe B.P., Saylor D.L., Speth R.C., and Absher D.R. Angiotensin-(1-7) binding at angiotensin II receptors in the rat brain. Regul Pept 56 (1995) 139-146
23. Sampaio W.O., Souza dos Santos R.A., Faria-Silva R., da Mata Machado L.T., Schiffrin E.L., and Touyz R.M. Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 49 (2007) 185-192
24. Santos R.A., and Ferreira A.J. Angiotensin-(1-7) and the renin-angiotensin system. Curr Opin Nephrol Hypertens 16 (2007) 122-128
25. Santos R.A., Ferreira A.J., and Simoes E.S.A.C. Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. Exp Physiol 93 (2008) 519-527
26. Santos R.A., Simoes e Silva A.C., Maric C., Silva D.M., Machado R.P., de Buhr I., et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 100 (2003) 8258-8263
27. Schiavone M.T., Santos R.A., Brosnihan K.B., Khosla M.C., and Ferrario C.M. Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide. Proc Natl Acad Sci USA 85 (1988) 4095-4098
28. Sys S.U., De Keulenaer G.W., and Brutsaert D.L. Physiopharmacological evaluation of myocardial performance: how to study modulation by cardiac endothelium and related humoral factors?. Cardiovasc Res 39 (1998) 136-147
29. Tipnis S.R., Hooper N.M., Hyde R., Karran E., Christie G., and Turner A.J. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275 (2000) 33238-33243
30. Yamada K., Iyer S.N., Chappell M.C., Ganten D., and Ferrario C.M. Converting enzyme determines plasma clearance of angiotensin-(1-7). Hypertension 32 (1998) 496-502